{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:30:26Z","timestamp":1794562226825,"version":"4.9.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA061215"],"award-info":[{"award-number":["R21DA061215"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA058110"],"award-info":[{"award-number":["R21DA058110"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008984","name":"International Anesthesia Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008984","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jpet.2026.105006","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T23:29:03Z","timestamp":1786145343000},"page":"105006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel drug sequestrant\u2013based therapeutic candidate reverses methamphetamine-induced hyperthermia and hypermetabolism and abates multiorgan toxicity in rats"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3526-0908","authenticated-orcid":false,"given":"Joseph F.","family":"Cotten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Marota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6185-1998","authenticated-orcid":false,"given":"Elie","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jpet.2026.105006_bib2","first-page":"1","article-title":"Emergency department management of methamphetamine toxicity","volume":"25","author":"Hicks","year":"2023","journal-title":"Emerg Med Pract"},{"issue":"3","key":"10.1016\/j.jpet.2026.105006_bib3","doi-asserted-by":"crossref","first-page":"482","DOI":"10.7150\/ijms.99159","article-title":"A mechanistic review on toxicity effects of methamphetamine","volume":"22","author":"Ramli","year":"2025","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jpet.2026.105006_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.01.040","article-title":"Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review","volume":"150","author":"Richards","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"16","key":"10.1016\/j.jpet.2026.105006_bib5","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/cbic.201700289","article-title":"Molecular containers bind drugs of abuse in vitro and reverse the hyperlocomotive effect of methamphetamine in rats","volume":"18","author":"Ganapati","year":"2017","journal-title":"Chembiochem"},{"issue":"21","key":"10.1016\/j.jpet.2026.105006_bib7","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1039\/D0CS00454E","article-title":"Supramolecular hosts as in vivo sequestration agents for pharmaceuticals and toxins","volume":"49","author":"Deng","year":"2020","journal-title":"Chem Soc Rev"},{"issue":"3","key":"10.1016\/j.jpet.2026.105006_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.coph.2006.11.009","article-title":"Selective relaxant binding agents for reversal of neuromuscular blockade","volume":"7","author":"Bom","year":"2007","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105006_bib9","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1016\/j.bja.2020.02.019","article-title":"Calabadion 1 selectively reverses respiratory and central nervous system effects of fentanyl in a rat model","volume":"125","author":"Thevathasan","year":"2020","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.jpet.2026.105006_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/ALN.0b013e3182910213","article-title":"Calabadion: a new agent to reverse the effects of benzylisoquinoline and steroidal neuromuscular-blocking agents","volume":"119","author":"Hoffmann","year":"2013","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.jpet.2026.105006_bib11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.121.000675","article-title":"A comparison of breathing stimulants for reversal of synthetic opioid-induced respiratory depression in conscious rats","volume":"378","author":"Dandrea","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.jpet.2026.105006_bib12","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.2967\/jnumed.107.040279","article-title":"PET studies of d-methamphetamine pharmacokinetics in primates: comparison with l-methamphetamine and ( --)-cocaine","volume":"48","author":"Fowler","year":"2007","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1016\/j.jpet.2026.105006_bib13","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0969-8051(93)90098-F","article-title":"Fluorine-18 and carbon-11 labeled amphetamine analogs--synthesis, distribution, binding characteristics in mice and rats and a PET study in monkey","volume":"20","author":"Shiue","year":"1993","journal-title":"Nucl Med Biol"},{"issue":"16","key":"10.1016\/j.jpet.2026.105006_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018370","article-title":"Methamphetamine-associated heart failure hospitalizations across the United States: geographic and social disparities","volume":"10","author":"Dickson","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.jpet.2026.105006_bib15","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s12272-021-01341-7","article-title":"Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson's disease","volume":"44","author":"Shin","year":"2021","journal-title":"Arch Pharm Res"},{"issue":"9","key":"10.1016\/j.jpet.2026.105006_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-230288","article-title":"Methamphetamine (N-methylamphetamine)-induced renal disease: underevaluated cause of end-stage renal disease (ESRD)","volume":"12","author":"Baradhi","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jpet.2026.105006_bib17","series-title":"Lead Exposure and Poisoning in Adults: Management","author":"Goldman","year":"2026"},{"issue":"4","key":"10.1016\/j.jpet.2026.105006_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/syn.20365","article-title":"Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling","volume":"61","author":"Melega","year":"2007","journal-title":"Synapse"},{"issue":"4990","key":"10.1016\/j.jpet.2026.105006_bib19","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/2061260a0","article-title":"Urinary excretion of methylamphetamine in man","volume":"206","author":"Beckett","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.jpet.2026.105006_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.938021","article-title":"Case report: successful intravenous lipid emulsion therapy for canine amphetamine toxicosis","volume":"9","author":"Harris","year":"2022","journal-title":"Front Vet Sci"},{"issue":"8","key":"10.1016\/j.jpet.2026.105006_bib21","doi-asserted-by":"crossref","first-page":"1732.e3","DOI":"10.1016\/j.ajem.2015.12.055","article-title":"The use of intravenous lipid emulsion therapy in acute methamphetamine toxicity","volume":"34","author":"Tse","year":"2016","journal-title":"Am J Emerg Med"},{"issue":"2","key":"10.1016\/j.jpet.2026.105006_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3181\/00379727-118-29904","article-title":"Acute lethality of the amphetamines in dogs and its antagonism by curare","volume":"118","author":"Zalis","year":"1965","journal-title":"Proc Soc Exp Biol Med"},{"issue":"4","key":"10.1016\/j.jpet.2026.105006_bib23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00213-023-06321-x","article-title":"Dantrolene sodium fails to reverse robust brain hyperthermia induced by MDMA and methamphetamine in rats","volume":"240","author":"Cameron-Burr","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"issue":"2-3","key":"10.1016\/j.jpet.2026.105006_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(98)00758-4","article-title":"Sympatho-adrenal involvement in methamphetamine-induced hyperthermia through skeletal muscle hypermetabolism","volume":"363","author":"Makisumi","year":"1998","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.jpet.2026.105006_bib25","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.chempr.2022.11.019","article-title":"Pillar[6]MaxQ: a potent supramolecular host for in vivo sequestration of methamphetamine and fentanyl","volume":"9","author":"Brockett","year":"2023","journal-title":"Chem"},{"issue":"2","key":"10.1016\/j.jpet.2026.105006_bib26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4161\/mabs.27620","article-title":"Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use","volume":"6","author":"Stevens","year":"2014","journal-title":"MAbs"},{"issue":"6","key":"10.1016\/j.jpet.2026.105006_bib27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nchem.1326","article-title":"Acyclic cucurbit[n]uril molecular containers enhance the solubility and bioactivity of poorly soluble pharmaceuticals","volume":"4","author":"Ma","year":"2012","journal-title":"Nat Chem"},{"issue":"2","key":"10.1016\/j.jpet.2026.105006_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/1098-2396(200102)39:2<161::AID-SYN7>3.0.CO;2-E","article-title":"Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse","volume":"39","author":"Cho","year":"2001","journal-title":"Synapse"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526012061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526012061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:19:30Z","timestamp":1794561570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526012061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0022356526012061"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105006","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel drug sequestrant\u2013based therapeutic candidate reverses methamphetamine-induced hyperthermia and hypermetabolism and abates multiorgan toxicity in rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"105006"}}